SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-056472
Filing Date
2022-05-05
Accepted
2022-05-05 16:23:17
Documents
39
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2214436d1_8k.htm   iXBRL 8-K 25086
2 EXHIBIT 99.1 tm2214436d1_ex99-1.htm EX-99.1 85423
3 EXHIBIT 99.2 tm2214436d1_ex99-2.htm EX-99.2 35219
7 GRAPHIC tm2214436d1_ex99-1img001.jpg GRAPHIC 5332
8 GRAPHIC tm2214436d1_ex99-2img001.jpg GRAPHIC 153434
9 GRAPHIC tm2214436d1_ex99-2img002.jpg GRAPHIC 422915
10 GRAPHIC tm2214436d1_ex99-2img003.jpg GRAPHIC 137332
11 GRAPHIC tm2214436d1_ex99-2img004.jpg GRAPHIC 170044
12 GRAPHIC tm2214436d1_ex99-2img005.jpg GRAPHIC 215636
13 GRAPHIC tm2214436d1_ex99-2img006.jpg GRAPHIC 150289
14 GRAPHIC tm2214436d1_ex99-2img007.jpg GRAPHIC 192225
15 GRAPHIC tm2214436d1_ex99-2img008.jpg GRAPHIC 111415
16 GRAPHIC tm2214436d1_ex99-2img009.jpg GRAPHIC 210149
17 GRAPHIC tm2214436d1_ex99-2img010.jpg GRAPHIC 155333
18 GRAPHIC tm2214436d1_ex99-2img012.jpg GRAPHIC 165623
19 GRAPHIC tm2214436d1_ex99-2img013.jpg GRAPHIC 134859
20 GRAPHIC tm2214436d1_ex99-2img014.jpg GRAPHIC 218999
21 GRAPHIC tm2214436d1_ex99-2img015.jpg GRAPHIC 185275
22 GRAPHIC tm2214436d1_ex99-2img016.jpg GRAPHIC 130382
23 GRAPHIC tm2214436d1_ex99-2img017.jpg GRAPHIC 135975
24 GRAPHIC tm2214436d1_ex99-2img019.jpg GRAPHIC 156457
25 GRAPHIC tm2214436d1_ex99-2img020.jpg GRAPHIC 174225
26 GRAPHIC tm2214436d1_ex99-2img021.jpg GRAPHIC 170127
27 GRAPHIC tm2214436d1_ex99-2img022.jpg GRAPHIC 162087
28 GRAPHIC tm2214436d1_ex99-2img023.jpg GRAPHIC 274161
29 GRAPHIC tm2214436d1_ex99-2img024.jpg GRAPHIC 128265
30 GRAPHIC tm2214436d1_ex99-2img025.jpg GRAPHIC 177629
31 GRAPHIC tm2214436d1_ex99-2img026.jpg GRAPHIC 196375
  Complete submission text file 0001104659-22-056472.txt   6293888

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tbph-20220505.xsd EX-101.SCH 3039
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20220505_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20220505_pre.xml EX-101.PRE 22599
33 EXTRACTED XBRL INSTANCE DOCUMENT tm2214436d1_8k_htm.xml XML 3621
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 22896693
SIC: 2834 Pharmaceutical Preparations